Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs)

被引：0
|
作者：
Bilton, Diana
Caine, Noreen
Cosgriff, Rebecca
Nyangoma, Stephen
Carr, Siobhan
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Cystic fibrosis; Lung function testing; Chronic disease;
D O I：
10.1183/13993003.congress-2016.PA4868
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4868
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Use of a rare disease patient registry in long-term post-authorisation drug studies: a model for collaboration with industry
    Bilton, Diana
    Caine, Noreen
    Cunningham, Steve
    Simmonds, Nicholas J.
    Cosgriff, Rebecca
    Carr, Siobhan B.
    [J]. LANCET RESPIRATORY MEDICINE, 2018, 6 (07): : 495 - 496
  • [2] ASSESSMENT OF DRUG SAFETY: POST-AUTHORISATION SAFETY STUDIES AND DRUG UTILIZATION STUDIES WITH SIDIAP PARTICIPATION
    Giner, M.
    Cortes, J.
    Quijada, M. A.
    Vlacho, B.
    Mustata, C.
    Morros, R.
    Prieto, D.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 : 16 - 17
  • [3] Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosis
    Barraco, Fiorenza
    Grei, Richard
    Herbrecht, Raoul
    Schmidt, Burkhard
    Reiter, Andreas
    Willenbacher, Wolfgang
    Raymakers, Reinier
    Liersch, Rudiger
    Wroclawska, Monika
    Pack, Robert
    Burock, Karin
    Karumanchi, Divyadeep
    Gisslinger, Heinz
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2020, 191 (05) : 764 - 774
  • [4] Interim Analysis of a Post-authorisation Safety Study on the Long-Term Safety of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in Patients with Primary Immunodeficiency Diseases in Europe
    Ellerbroek, P. M.
    Van Paassen, P.
    Hanitsch, L.
    Plebani, A.
    Schmidt, R. E.
    Van Hagen, P. M.
    Wang, P.
    Fielhauers, K.
    Leibls, H.
    Chavan, S.
    Yel, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 402 - 403
  • [5] Empowering a database with national long-term data about mortality: the use of national death registries
    Morales, David L. S.
    McClellan, Andrew J.
    Jacobs, Jeffrey P.
    [J]. CARDIOLOGY IN THE YOUNG, 2008, 18 : 188 - 195
  • [6] Global Increlex® Registry, post-authorisation surveillance registry monitoring the long-term safety and effectiveness of mecasermin in children and adolescents with Severe Primary IGFD (SPIGFD): objectives and study design
    Bang, Peter
    Mazain, Sarah
    Perrot, Valerie
    Sert, Caroline
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 296 - 296
  • [7] Food and drug administration panel recommends diabetes drug manufacturers to conduct long-term studies on cardiovascular outcomes
    Idris, Iskandar
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 (09): : 807 - 807
  • [8] Novel use of harmonized data quality indicators in long-term safety studies using multiple sclerosis registries: Approach in CLARION study
    Magyari, Melinda
    Moore, Nicholas
    Wergeland, Stig
    Sonajalg, Jaak
    Meritxell, Sabid O.
    Aydemir, Aida
    Bezemer, Irene
    Ziemssen, Tjalf
    Kuhle, Jens
    Soilu-Hanninen, Merja
    Butzkueven, Helmut
    Hillert, Jan
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 646 - 647
  • [9] An update on the safety of long-term vedolizumab use in inflammatory bowel disease
    Honap, Sailish
    Netter, Patrick
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    [J]. EXPERT OPINION ON DRUG SAFETY, 2023, : 767 - 776
  • [10] An update on the safety of long-term vedolizumab use in inflammatory bowel disease
    Honap, Sailish
    Netter, Patrick
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    [J]. EXPERT OPINION ON DRUG SAFETY, 2023,
12345